Abstract
Objective-To assess the morbidity and mortality associated with a prenatal diagnosis of bilateral fetal uropathy.
Design-Retrospective study. Setting-Departments of radiology, paediatric surgery, obstetrics, and pathology in two teaching hospitals that serve as referral centres for the Yorkshire region.
Patients-126 Cases of fetal uropathy were referred either prenatally or postnatally from hospitals in Yorkshire between August 1982 and December 1987. The disease was bilateral in 54 cases and unilateral in 72 cases. In 14 cases bilateral fetal uropathy was associated with coexistent disease.
Interventions-All cases were managed individually by an obstetrician after discussion with the radiologists and paediatric surgeons. Babies who survived were treated prophylactically with antibiotics after delivery and were operated on if appropriate.
End point-Assessment of prognosis for long term renal function for each baby referred between August 1982 and December 1987: follow up ranged from six months to five years.
Measurements and main results-Of the 54 fetuses with bilateral fetal uropathy, 13 were terminated as the prenatal findings of ultrasonography were considered to be incompatible with long term survival. Ten of the liveborn babies died, five of renal or pulmonary insufficiency, or both, and five of associated congenital anomalies. Thirty one infants survived to foliow up; four of these had serious coexistent disease and two had impaired renal function. Thus the overall mortality was 43% and the morbidity rate 19%. The renal anomaly was associated with other serious disease in 14 cases (26%) compared with two (3%) of the 72 cases of unilateral fetal uropathy. All but two of the 27 infants with isolated bilateral urinary tract disease had excellent prospects for survival.
Conclusion-Although bilateral fetal uropathy is associated with a high morbidity rate and mortality, careful prenatal assessment can help to identify fetuses with a poor prognosis. The outlook for a fetus with isolated renal disease if treated promptly after delivery is excellent and compares favourably with that reported after prenatal surgical intervention.
Introduction
Detection of fetal urinary tract anomalies may be valuable for both prenatal and postnatal management, particularly when the abnormality is bilateral.' The potential benefit is, however, offset by the poor prognosis often associated with bilateral fetal uropathy. Doctors had hoped that the introduction of fetal surgery would help to reduce the morbidity and mortality associated with this disease by preventing pulmonary hypoplasia and progressive impairment of renal function. Several recent studies have discussed the possible benefits of decompressing the fetal urinary tract surgically.2" Though the authors generally accepted that intervention is not justified for unilateral disease, they disagreed about the management of bilateral disease. We carried out a study to establish the morbidity and mortality associated with bilateral fetal uropathy, with particular reference to the incidence of coexistent congenital abnormalities and the long term outlook for renal function.
Patients and methods
Between August 1982 and December 1987, 126 cases of fetal uropathy were referred to our units either prenatally or postnatally for further assessment. The disease was bilateral in 54 cases; 28 of these were from our own districts, and 26 were referred from other hospitals throughout the Yorkshire region. Most of the anomalies had been detected by routine antenatal ultrasonography, which is normally performed at 17-19 weeks of gestation. There was no fixed policy for following these cases as generally we considered that each case should be managed individually and that the severity of the abnormality should be taken into consideration.
We reviewed the prenatal and postnatal records, including necropsy reports if appropriate, and assessed the incidence of congenital abnormalities in fetuses with unilateral and bilateral uropathy. Cases of equivocal dilatation of the urinary tract were omitted. Routine ultrasonography is performed on at least 95% of all pregnant women in Leeds, allowing us to estimate the overall incidence of fetal anomalies in the population.
Results
During the study 46 775 pregnancies were registered in Leeds. We saw 78 fetuses with an important urinary tract anomaly; the disease was bilateral in 28 of these. This gave an incidence of all anomalies of the urinary tract of 1 in 600 pregnancies and an incidence of bilateral fetal uropathy of 1 in 1670 pregnancies.
Thirteen of the 54 fetuses with bilateral uropathy were terminated as the antenatal findings were incompatible with long term survival; eight had a primary urinary tract anomaly and in five the uropathy BMJ VOLUME 298 27 MAY 1989 The liveborn babies were all investigated as soon as possible after delivery by ultrasonography, and micturating cystourethrography and isotope scanning were performed if appropriate. Intravenous urography was performed in the few cases in which the diagnosis was still uncertain after the initial investigations. Although these results cannot be compared with those in other studies after intrauterine intervention as our groups were not matched, they suggest that prompt treatment of babies with isolated urinary tract disease is often associated with a good prognosis, and intrauterine surgery probably would not have improved the outcome in these babies.
The incidence of coexistent disease (26%) in this study was high. This is an important factor when considering prenatal intervention. Prenatal surgery may be ineffective and inappropriate for a fetus with a severe congenital anomaly or chromosomal disorder. Although ultrasonography and karyotype analysis may detect many of the coexistent anomalies, several important abnormalities will remain undetected prenatally. Furthermore, Scott and Renwick reported the limitations of prenatal diagnoses,9 and Sholder et al concluded that it is difficult to justify invasive in utero procedures in view of the inability to differentiate accurately between obstructive and non-obstructive hydronephrosis.'°We conclude that the specificity of prenatal diagnosis needs to be improved to prevent doctors performing unnecessary and potentially harmful prenatal operations.
